fbpx
QQQ
+ 0.43
303.42
+ 0.14%
DIA
+ 0.85
298.31
+ 0.28%
SPY
-0.15
366.97
-0.04%
TLT
+ 1.26
154.99
+ 0.81%
GLD
+ 1.27
170.26
+ 0.74%

Tobacco Company Imperial Brands, Auxly Cannabis Close On Partnership, $92.8M Investment

September 26, 2019 9:37 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Auxly Cannabis Group Inc. (OTC:CBWTFannounced Wednesday the closing of a transaction with Imperial Tobacco Group plc (OTC:IMBBY).

As previously announced in July, Imperial Brands invested CA$123 million ($92.8 million) in Auxly by way of a debenture that is convertible into 19.9% ownership of the cannabis company. 

Imperial is providing Auxly with global licenses to its vaping technology and access to its vapor innovation business, and will make Auxly its exclusive partner for its cannabis business operations, according to Wednesday's announcement. 

“We are delighted to announce the closing of this transaction to formally mark the start of our strategic partnership with Imperial Brands,” Auxly CEO Hugo Alves said in a statement.

“We believe there is considerable opportunity for growth and value creation for both companies. We are looking forward to working with the incredibly strong team at Imperial Brands as we prepare to launch our portfolio of branded derivative products, formulated and manufactured at our subsidiary, Dosecann, later this year. “

 Click here for more information about the upcoming Benzinga Cannabis Capital Conference Oct. 22-23 in Chicago.

Auxly is appointing Imperial's Conrad Tate to its board as a director and John Downing as a non-voting observer. 

“I’m thrilled to be closing this transaction with Auxly, a dynamic, highly skilled organization that has all the ingredients required for delivering success in the branded derivatives market and beyond,” Tate, Imperial Brands' new corporate development director, said in a statement.

“We’re excited by the opportunities this partnership offers and look forward to working with Auxly to build its business and realize its significant future growth potential.”

Don’t miss out on the top cannabis stories of the day. Click here to sign up for our daily insider newsletter.

Photo courtesy of Imperial Brands. 


Related Articles

Emerald Health Pharmaceuticals To Raise $17M Via New Reg A+ Round

Emerald Health Pharmaceuticals Inc. (EHP) is launching a new financing round under its Regulation A offering. The round will open on Monday, Dec. 7, and expire on Mar. 28, 2021, or upon raising roughly $17 million, which is the maximum amount to be raised, the Sand Diego biotech company said. read more

Acreage Ensures $12M Loan To Expand Illinois Facility

Acreage Holdings Inc. (OTCQX: ACRHF) revealed it is getting a $12 million construction financing loan to support the development of its cultivation and processing facility in Illinois. read more

Earnings Roundup: iAnthus, Can-Fite, Organigram, Bluma Wellness, Auxly

iAnthus Touts 82% YoY Revenue Growth, Names Interim COO read more

Sundial Announces Elimination Of Senior Secured Second Lien Convertible Notes; Says Holder Of Sundial Senior Secured Second Lien Convertible Notes Has Fully Converted All Notes From The Original Issuance Of $73.2M On Jun. 5, 2020

CALGARY, AB, Nov. 30, 2020 /PRNewswire/ - Sundial Growers Inc. (NASDAQ:SNDL) ("Sundial" or the "Company") provides an update on the elimination of its senior secured second lien convertible read more

AgraFlora Secures Agriculture Loan To Support Phase 1 Cultivation Strategy

AgraFlora Organics International Inc. (CSE: AGRA) (PINK: AGFAF) said its joint venture venture with the Houwelings Group — Propagation Services Can read more